PATH-26. NEURO-ONCOLOGY NEXT-GENERATION SEQUENCING 219-GENE PANEL FOR COMPREHENSIVE CLINICAL TESTING

Molecular parameters were incorporated in the WHO classification of central nervous system (CNS) tumors. Despite advances in understanding the molecular biology of CNS tumors, targetable genomic abnormalities are lacking. To identify diagnostically, prognostically and potential therapeutically relev...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Neuro Oncol
Auteurs principaux: Ida, Cristiane, Barr Fritcher, Emily, Zysk, Christopher, Voss, Jesse, Wu, Xianglin, Balan, Jagadheshwar, Kollmeyer, Thomas, Raghunathan, Aditya, Giannini, Caterina, Klee, Eric, Kipp, Benjamin, Jenkins, Robert
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2018
Sujets:
Abstracts
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6216644/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.682
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires